Chief Financial Officer
M.B. Chinappa is the Chief Financial Officer of Biocon Biologics. Since taking over as CFO in 2019, he has been driving the financial performance of the company, strengthening the finance function to support future growth, improving profitability and managing anticipated risks.
Chinappa is a veteran at Biocon, having spent over 20 years in the organisation. At Biocon, he was initially part of the finance team and a member of its Core Committee. He was involved in several strategic initiatives including raising private equity funds to finance Biocon’s foray into biopharmaceuticals, Biocon’s listing on the capital markets, getting Special Economic Zone status for Biocon Park and setting up the Joint Venture with CIMAB, Cuba to mark Biocon’s entry into Biologics.
Subsequently, he moved to Biocon’s subsidiary, Syngene, as the CFO in 2008 where he played a significant role in driving the growth of the company. Besides finance, he also oversaw other supporting functions like Supply Chain Management, IT, E&M and Legal. He also led the highly successful Initial Public Offering (IPO) of Syngene in 2015.
Prior to joining the Biocon Group in 1999, he worked at ITC Ltd for 7 years.
Chinappa is a Chartered Accountant by qualification with nearly 30 years of experience in Corporate Finance, Planning, Treasury, Taxation, Risk Management and Assurance.